TY  - JOUR

T1  - PCN11 COST-UTILITY ANALYSIS OF DASATINIB IN PATIENTS AFTER FIRST-LINE FAILURE OF IMATINIB IN CHRONIC MYELOID LEUKEMIA (CML) IN AUSTRIA

JO  - Value in Health

PY  - 2007/11/05

AU  - Logman JFS

AU  - Taylor MJ

AU  - Neumann K

AU  - Kutikova L

AU  - Cerri KH

AU  - Van Hout BA

AU  - Kühr T

ED  - 

DO  - DOI: 10.1016/s1098-3015(10)65169-8

PB  - Elsevier BV

VL  - 10

IS  - 6

SP  - A325

EP  - A325

Y2  - 2024/10/22

ER  -